Human Herpesvirus 6B Greatly Increases Risk of Depression by Activating Hypothalamic-Pituitary -Adrenal Axis during Latent Phase of Infection
- PMID: 32534440
- PMCID: PMC7298549
- DOI: 10.1016/j.isci.2020.101187
Human Herpesvirus 6B Greatly Increases Risk of Depression by Activating Hypothalamic-Pituitary -Adrenal Axis during Latent Phase of Infection
Abstract
Little is known about the effect of latent-phase herpesviruses on their host. Human herpesvirus 6B (HHV-6B) is one of the most ubiquitous herpesviruses, and olfactory astrocytes are one of the most important sites of its latency. Here, we identified SITH-1, an HHV-6B latent protein specifically expressed in astrocytes. Mice induced to produce SITH-1 in their olfactory astrocytes exhibited olfactory bulb apoptosis, a hyper-activated hypothalamic-pituitary-adrenal (HPA) axis and depressive symptoms. The binding of SITH-1 to the host protein calcium-modulating ligand (CAML) to form an activated complex promoted the influx of extracellular calcium. The serum antibody titers for depressive patients with respect to this activated complex were significantly higher than for normal controls (p = 1.78 × 10-15), when the antibody positive rates were 79.8% and 24.4%, respectively, and the odds ratio was 12.2. These results suggest that, in the latent phase, HHV-6B may be involved in the onset of depression.
Keywords: Behavioral Neuroscience; Molecular Biology; Virology.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests K.K. and N.K. have submitted a patent application entitled “Factor involved in latent infection with herpesvirus, and use thereof,” US patent application publication 2010/0281550 A1. N.O., K.K., and N.K. have submitted a patent application entitled “Method for detecting antibody against SITH-1 in biological sample,” US patent application publication 2012/0107842 A1. K.K. has submitted a patent application entitled “Methods for Assessing Fatigue Level and Applications Thereof,” US patent application publication 2008/0280283 A1. K.K. reports grants and non-financial support from Virus Ikagaku Kenkyusho Inc. In addition, K.K. has stock in Virus Ikagaku Kenkyusho Inc. None of the material has been published or is under consideration by any other journals.
Figures
Similar articles
-
Relationship between human herpesvirus 6 infection and inflammatory bowel disease using novel biomarker.JGH Open. 2023 Nov 2;7(11):790-796. doi: 10.1002/jgh3.12992. eCollection 2023 Nov. JGH Open. 2023. PMID: 38034055 Free PMC article.
-
RNA Sequencing of the In Vivo Human Herpesvirus 6B Transcriptome To Identify Targets for Clinical Assays Distinguishing between Latent and Active Infections.J Virol. 2019 Jan 17;93(3):e01419-18. doi: 10.1128/JVI.01419-18. Print 2019 Feb 1. J Virol. 2019. PMID: 30429336 Free PMC article.
-
An Animal Model That Mimics Human Herpesvirus 6B Pathogenesis.J Virol. 2020 Feb 28;94(6):e01851-19. doi: 10.1128/JVI.01851-19. Print 2020 Feb 28. J Virol. 2020. PMID: 31852793 Free PMC article.
-
Molecular biology of human herpesviruses 6A and 6B.Infect Agents Dis. 1993 Dec;2(6):343-60. Infect Agents Dis. 1993. PMID: 8012736 Review.
-
HHV-6A, 6B, and 7: molecular basis of latency and reactivation.In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 47. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 47. PMID: 21348064 Free Books & Documents. Review.
Cited by
-
Identification of a strong genetic risk factor for major depressive disorder in the human virome.iScience. 2024 Feb 10;27(3):109203. doi: 10.1016/j.isci.2024.109203. eCollection 2024 Mar 15. iScience. 2024. PMID: 38414857 Free PMC article.
-
Relationship between human herpesvirus 6 infection and inflammatory bowel disease using novel biomarker.JGH Open. 2023 Nov 2;7(11):790-796. doi: 10.1002/jgh3.12992. eCollection 2023 Nov. JGH Open. 2023. PMID: 38034055 Free PMC article.
-
The Association of HHV-6 and the TNF-α (-308G/A) Promotor with Major Depressive Disorder Patients and Healthy Controls in Thailand.Viruses. 2023 Sep 8;15(9):1898. doi: 10.3390/v15091898. Viruses. 2023. PMID: 37766304 Free PMC article.
-
Exploring New Mechanism of Depression from the Effects of Virus on Nerve Cells.Cells. 2023 Jul 3;12(13):1767. doi: 10.3390/cells12131767. Cells. 2023. PMID: 37443801 Free PMC article. Review.
-
SARS-CoV-2 S1 protein causes brain inflammation by reducing intracerebral acetylcholine production.iScience. 2023 Jun 16;26(6):106954. doi: 10.1016/j.isci.2023.106954. Epub 2023 May 24. iScience. 2023. PMID: 37275532 Free PMC article.
References
-
- Aoki R., Kobayashi N., Suzuki G., Kuratsune H., Shimada K., Oka N., Takahashi M., Yamadera W., Iwashita M., Tokuno S. Human herpesvirus 6 and 7 are biomarkers for fatigue, which distinguish between physiological fatigue and pathological fatigue. Biochem. Biophysical Res. Commun. 2016;478:424–430. - PubMed
-
- Belmaker R.H., Agam G. Major depressive disorder. N. Engl. J. Med. 2008;358:55–68. - PubMed
-
- Conejero-Goldberg C., Torrey E.F., Yolken R.H. Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophr Res. 2003;60:65–69. - PubMed
-
- Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke S., Wray N.R., Lewis C.M., Hamilton S.P., Weissman M.M., Breen G., Byrne E.M., Blackwood D.H., Boomsma D.I. A mega-analysis of genome-wide association studies for major depressive disorder. Mol. Psychiatry. 2013;18:497–511. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
